Zobrazeno 1 - 10
of 47
pro vyhledávání: '"Yulan Deng"'
Publikováno v:
Frontiers in Pharmacology, Vol 13 (2022)
Background: The role of the tumor microenvironment (TME) in predicting prognosis and therapeutic efficacy has been demonstrated. Nonetheless, no systematic studies have focused on TME patterns or their function in the effectiveness of immunotherapy i
Externí odkaz:
https://doaj.org/article/7b309ae53d2442e18f5592e39f92437d
Publikováno v:
Frontiers in Bioscience-Landmark, Vol 28, Iss 6, p 107 (2023)
Background: The purpose of our study is to analyze the expression pattern and prognostic value of catabolism-related enzymes of branched-chain amino acids (BCAAs) in non-small cell lung cancer (NSCLC). Methods: Differential expression analysis, mutat
Externí odkaz:
https://doaj.org/article/a9016f84440f498d95decf17c0c4deea
Publikováno v:
Frontiers in Oncology, Vol 11 (2021)
BackgroundStratification of patients who could benefit from immune checkpoint inhibitor (ICI) therapy is of much importance. PD-1hiCD8+ T cells represent a newly identified and effective biomarker for ICI therapy response biomarker in lung cancer. Ac
Externí odkaz:
https://doaj.org/article/0c06da6ca22e4e7d931cc79d8fa81e93
Autor:
Yulan Deng, Shangyi Luo, Xinxin Zhang, Chaoxia Zou, Huating Yuan, Gaoming Liao, Liwen Xu, Chunyu Deng, Yujia Lan, Tingting Zhao, Xu Gao, Yun Xiao, Xia Li
Publikováno v:
Molecular Oncology, Vol 12, Iss 11, Pp 1980-2005 (2018)
Substantial cancer genome sequencing efforts have discovered many important driver genes contributing to tumorigenesis. However, very little is known about the genetic alterations of long non‐coding RNAs (lncRNAs) in cancer. Thus, there is a need f
Externí odkaz:
https://doaj.org/article/fe011ec146334a84aaee13183d4cba19
Publikováno v:
Sensors, Vol 21, Iss 13, p 4597 (2021)
Age estimation from face images has attracted much attention due to its favorable and many real-world applications such as video surveillance and social networking. However, most existing studies usually learn a single kind of age feature and ignore
Externí odkaz:
https://doaj.org/article/2139848f9d774390963faa88d1e709bc
Autor:
Li Wang, Yun Xiao, Yanyan Ping, Jing Li, Hongying Zhao, Feng Li, Jing Hu, Hongyi Zhang, Yulan Deng, Jiawei Tian, Xia Li
Publikováno v:
PLoS ONE, Vol 14, Iss 8, p e0221483 (2019)
[This corrects the article DOI: 10.1371/journal.pone.0104282.].
Externí odkaz:
https://doaj.org/article/45ebbf964f794a6f96a2f356e65c832c
Autor:
Li Wang, Yun Xiao, Yanyan Ping, Jing Li, Hongying Zhao, Feng Li, Jing Hu, Hongyi Zhang, Yulan Deng, Jiawei Tian, Xia Li
Publikováno v:
PLoS ONE, Vol 9, Iss 8, p e104282 (2014)
Cross-talk among abnormal pathways widely occurs in human cancer and generally leads to insensitivity to cancer treatment. Moreover, alterations in the abnormal pathways are not limited to single molecular level. Therefore, we proposed a strategy tha
Externí odkaz:
https://doaj.org/article/bc410bf4c750461693afa8d6ab0315a0
Autor:
Lunxu Liu, Longqi Chen, Guowei Che, Zhu Wu, Yun Wang, Yingli Kou, Xiaolong Zhang, Weizhi Chen, Ji He, Qingyun Li, Chuan Li, Kaidi Li, Yuyang Xu, Zheng Liu, Wenping Wang, Yunke Zhu, Chengwu Liu, Hu Liao, Chenglin Guo, Yang Hu, Yong Yuan, Feng Lin, Lin Ma, Qiang Pu, Yidan Lin, Fanyi Gan, Yulan Deng, Gang Feng, Ying Yang, Yaohui Chen, Senyi Deng, Ran Kang, Jiandong Mei, Liang Xia
Supplementary Data from Perioperative ctDNA-Based Molecular Residual Disease Detection for Non–Small Cell Lung Cancer: A Prospective Multicenter Cohort Study (LUNGCA-1)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::009f0cdeff8dc5fc1587286d7ba1d720
https://doi.org/10.1158/1078-0432.22487901
https://doi.org/10.1158/1078-0432.22487901
Autor:
Lunxu Liu, Longqi Chen, Guowei Che, Zhu Wu, Yun Wang, Yingli Kou, Xiaolong Zhang, Weizhi Chen, Ji He, Qingyun Li, Chuan Li, Kaidi Li, Yuyang Xu, Zheng Liu, Wenping Wang, Yunke Zhu, Chengwu Liu, Hu Liao, Chenglin Guo, Yang Hu, Yong Yuan, Feng Lin, Lin Ma, Qiang Pu, Yidan Lin, Fanyi Gan, Yulan Deng, Gang Feng, Ying Yang, Yaohui Chen, Senyi Deng, Ran Kang, Jiandong Mei, Liang Xia
Purpose:We assessed whether perioperative circulating tumor DNA (ctDNA) could be a biomarker for early detection of molecular residual disease (MRD) and prediction of postoperative relapse in resected non–small cell lung cancer (NSCLC).Experimental
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::03bf91bb0ff0601d313cb46d01117f51
https://doi.org/10.1158/1078-0432.c.6532605
https://doi.org/10.1158/1078-0432.c.6532605
Autor:
Fanyi Gan, Zhu Wu, Lunxu Liu, Weizhi Chen, Chengwu Liu, Yaohui Chen, Zheng Liu, Xiaolong Zhang, Yi-Dan Lin, Yong Yuan, Chuan Li, Gang Feng, Yunke Zhu, Lin Ma, Qiang Pu, Senyi Deng, Hu Liao, Chenglin Guo, Guowei Che, Ji He, Kaidi Li, Yun Wang, Ying-Li Kou, Feng Lin, Qingyun Li, Jiandong Mei, Wen-Ping Wang, Yuyang Xu, Ran Kang, Yulan Deng, Yang Hu, Liang Xia, Long-Qi Chen, Yang Ying
Publikováno v:
Clinical Cancer Research. 28:3308-3317
Purpose: We assessed whether perioperative circulating tumor DNA (ctDNA) could be a biomarker for early detection of molecular residual disease (MRD) and prediction of postoperative relapse in resected non–small cell lung cancer (NSCLC). Experiment